KLOW Blend Peptide 80mg
KLOW Blend is a research peptide formulation combining BPC-157, TB-500, KPV, and GHK-Cu in a single blend. It is studied for peptide signaling, inflammatory pathways, tissue regeneration, extracellular matrix remodeling, angiogenesis, and cellular repair mechanisms.
Certificate of Analysis
Compound information
What is BPC-157?
A synthetic 15-amino-acid peptide based on a protective protein found in gastric juice. Studied for cytoprotection and tissue repair, it acts largely through nitric-oxide signaling and VEGF-driven angiogenesis. Its proline-rich sequence gives it notable structural stability in laboratory models.
BPC-157 structure
Stability information
What is GHK-Cu?
A copper-bound tripeptide (glycyl-L-histidyl-L-lysine) first isolated from human plasma. It carries copper into cells and is studied for collagen synthesis and extracellular-matrix remodeling. Circulating levels fall with age, which is what first drew research attention to it.
GHK-Cu structure
Stability information
What is TB-500?
A synthetic fragment corresponding to the actin-binding region of thymosin beta-4. Built around the LKKTETQ motif, it is studied for actin regulation and cell migration toward sites of injury, making it a common tool in wound and repair research.
TB-500 structure
Stability information
What is KPV?
A tripeptide (lysine-proline-valine) taken from the tail end of the hormone alpha-MSH. It keeps the parent hormone's anti-inflammatory activity while dropping its pigment effect, and is studied for calming inflammatory signaling through NF-κB.
KPV structure
Stability information
Product overview
A four-compound repair and recovery research blend supplied at a ≥99% HPLC analytical standard per peptide.
Technical overview
KLOW brings together four research compounds whose mechanisms sit in different parts of the repair process. BPC-157 supports angiogenesis and cytoprotection, TB-500 drives actin-based cell migration, GHK-Cu supplies copper-dependent matrix remodeling, and KPV modulates inflammatory signaling.
Each peptide is synthesized and purified separately, quantified individually, and co-lyophilized into one vial, then released against a lot-matched Certificate of Analysis carrying HPLC purity and LC-MS identity.
Research applications
The blend is used in laboratory models that examine repair as a combined process rather than a single pathway. Typical work covers wound-closure and re-epithelialization assays, fibroblast and collagen-synthesis studies, angiogenesis and endothelial-migration models, and inflammation panels measuring cytokines such as TNF-α and IL-6 across all four mechanisms simultaneously.
Kylo Peptides supplies this compound as a reference material for scientific inquiry. All applications must be conducted by qualified professionals in controlled laboratory environments. It has not been evaluated by the FDA and is not intended to diagnose, treat, cure, or prevent any disease.
Frequently Researched Together
Frequently Asked Questions About KLOW Blend
KLOW combines four research peptides in one vial: BPC-157 at 10mg, GHK-Cu at 50mg, TB-500 at 10mg, and KPV at 10mg, for 80mg total. Each is synthesized and quantified separately, then co-lyophilized so the ratio is fixed and documented.
Each addresses a different part of tissue repair. BPC-157 supports blood-vessel formation, TB-500 promotes cell migration, GHK-Cu drives matrix and collagen remodeling, and KPV tempers inflammation. Researchers study them together to look at repair as an overlapping system rather than testing one mechanism in isolation.
Each peptide in the blend is supplied at ≥99% purity by HPLC, with identity confirmed by LC-MS and each component quantified separately. The lot passes independent third-party testing before release, and its certificate is published against the lot number on the vial.
Keep the lyophilized powder at −20 °C, sealed, dry, and out of light, with −80 °C suited to long-term storage. After reconstitution, hold the solution at 2 to 8 °C, use it within a validated window, and avoid repeated freeze-thaw cycles that can degrade the peptides.
Each compound is measured on its own. The certificate lists BPC-157, GHK-Cu, TB-500, and KPV separately, with the purity and identity of each, rather than reporting a single combined figure, so the exact content of every component is documented.
No. KLOW is intended for in vitro laboratory research only. It is not formulated, packaged, or labeled for human or veterinary use, and it is supplied strictly as a reference material for qualified researchers.
Backed By A Lot-Matched COA
Every KLOW Blend order is tied to a certificate of analysis quantifying all four compounds against the exact lot in your vial.
Shop catalog →
